Self-buffering capacity of a human sulfatase for central nervous system delivery
Abstract Direct delivery of therapeutic enzymes to the Central Nervous System requires stringent formulation design. Not only should the formulation design consider the delicate balance of existing ions, proteins, and osmolality in the cerebrospinal fluid, it must also provide long term efficacy and...
Guardado en:
Autores principales: | Yi Wen, Nazila Salamat-Miller, Keethkumar Jain, Katherine Taylor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1400d1c04e6a4582b16f39e102a5ed4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Freeze–thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics
por: Keethkumar Jain, et al.
Publicado: (2021) -
Acidity and buffering capacity of Iranian Woods
por: Ahmad Jahan latibari, et al.
Publicado: (1997) -
Human sulfatase transiently and functionally active expressed in E. coli K12
por: Poutou-Piñales,Raúl A, et al.
Publicado: (2010) -
The Discovery of the Buffer Capacity of Various Types of Polyelectrolyte Microcapsules
por: Alexey V. Dubrovskii, et al.
Publicado: (2021) -
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
por: Mykhaylo Demydchuk, et al.
Publicado: (2017)